|
|
Previous Article | Table of Contents | Next Article 
Platelet alpha-granule and plasma membrane share two new components: CD9
and PECAM-1
EM Cramer, G Berger and MC Berndt
Inserm U.348, Hopital Lariboisiere, Paris, France.
CD9 (p24) and PECAM1 (CD31) antigens are well-defined components of the
platelet plasma membrane. Both are integral glycoproteins (GPs) implicated
in the adhesive and aggregative properties of human platelets. In the
present report, we have investigated their subcellular localization using
immunoelectron microscopy. The monospecificity of the two polyclonal
antibodies used was confirmed by immunoblotting. On normal resting
platelets, immunolabeling for CD9 and PECAM1 was found lining the plasma
membrane and the luminal face of the open canalicular system. Some labeling
was also consistently found on the alpha-granule limiting membrane. This
was confirmed by double labeling experiments in which fibrinogen and von
Willebrand factor (vWF) were used as alpha-granule markers. CD9 and PECAM-1
were found lining the membrane of the same granules that contained
fibrinogen and vWF in their matrix. CD9 and PECAM-1 thus appear to have an
intracellular distribution identical to GPIIb-IIIa, a major aggregation
platelet receptor. To rule out a cross-reactivity of the two polyclonal
antibodies with GPIIb/IIIa, we studied PECAM1 and CD9 expression on the
platelets from a patient with type I Glanzmann's thrombasthenia whose
platelets are devoid of GPIIb/IIIa. The same pattern of labeling was
observed for both antigens as for normal platelets. Normal platelets were
further observed after stimulation by agonists that either fail to induce
(ADP) or induce granule secretion (thrombin). After treatment with ADP,
platelets changed shape and centralized their granules; the plasma membrane
immunolabeling remained unchanged; and gold particles were still found
decorating the periphery of the centralized alpha- granules. After thrombin
treatment, alpha-granules fused with the platelet membrane and secretion
occurred. A significant increase of labeling was then observed on the
platelet surface. From these results we conclude that the alpha-granule
membrane contains two additional receptors in common with the plasma
membrane. This suggests that alpha- granule membrane receptors may
originate from a dual mechanism: direct targeting from the Golgi complex in
megakaryocytes (for alpha-granule- specific receptors such as P-selectin)
or by endocytosis from the plasma membrane (for proteins distributed in the
two compartments).
Volume 84,
Issue 6,
pp. 1722-1730,
09/15/1994
Copyright © 1994 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. W. Goschnick, L.-M. Lau, J. L. Wee, Y. S. Liu, P. M. Hogarth, L. M. Robb, M. J. Hickey, M. D. Wright, and D. E. Jackson
Impaired "outside-in" integrin {alpha}IIbbeta3 signaling and thrombus stability in TSSC6-deficient mice
Blood,
September 15, 2006;
108(6):
1911 - 1918.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Limaye, X. Li, C. Hahn, P. Xia, M. C. Berndt, M. A. Vadas, and J. R. Gamble
Sphingosine kinase-1 enhances endothelial cell survival through a PECAM-1-dependent activation of PI-3K/Akt and regulation of Bcl-2 family members
Blood,
April 15, 2005;
105(8):
3169 - 3177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Huber, E. M. Cramer, J. E. Kaufmann, P. Meda, J.-M. Masse, E. K. O. Kruithof, and U. M. Vischer
Tissue-type plasminogen activator (t-PA) is stored in Weibel-Palade bodies in human endothelial cells both in vitro and in vivo
Blood,
May 15, 2002;
99(10):
3637 - 3645.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Wiewrodt, A. P. Thomas, L. Cipelletti, M. Christofidou-Solomidou, D. A. Weitz, S. I. Feinstein, D. Schaffer, S. M. Albelda, M. Koval, and V. R. Muzykantov
Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells
Blood,
February 1, 2002;
99(3):
912 - 922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mahooti, D. Graesser, S. Patil, P. Newman, G. Duncan, T. Mak, and J. A. Madri
PECAM-1 (CD31) Expression Modulates Bleeding Time in Vivo
Am. J. Pathol.,
July 1, 2000;
157(1):
75 - 81.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Croce, R. Flaumenhaft, M. Rivers, B. Furie, B. C. Furie, I. M. Herman, and D. A. Potter
Inhibition of Calpain Blocks Platelet Secretion, Aggregation, and Spreading
J. Biol. Chem.,
December 17, 1999;
274(51):
36321 - 36327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Witko-Sarsat, E. M. Cramer, C. Hieblot, J. Guichard, P. Nusbaum, S. Lopez, P. Lesavre, and L. Halbwachs-Mecarelli
Presence of Proteinase 3 in Secretory Vesicles: Evidence of a Novel, Highly Mobilizable Intracellular Pool Distinct From Azurophil Granules
Blood,
October 1, 1999;
94(7):
2487 - 2496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. L. Serebruany and P. A. Gurbel
Effect of Thrombolytic Therapy on Platelet Expression and Plasma Concentration of PECAM-1 (CD31) in Patients With Acute Myocardial Infarction
Arterioscler. Thromb. Vasc. Biol.,
January 1, 1999;
19(1):
153 - 158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-W. Wu and E. C.-Y. Lian
Binding Properties and Inhibition of Platelet Aggregation by a Monoclonal Antibody to CD31 (PECAM-1)
Arterioscler. Thromb. Vasc. Biol.,
November 1, 1997;
17(11):
3154 - 3158.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Youssefian, J.-M. Masse, F. Rendu, J. Guichard, and E. M. Cramer
Platelet and Megakaryocyte Dense Granules Contain Glycoproteins Ib and IIb-IIIa
Blood,
June 1, 1997;
89(11):
4047 - 4057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cicmil, J. M. Thomas, T. Sage, F. A. Barry, M. Leduc, C. Bon, and J. M. Gibbins
Collagen, Convulxin, and Thrombin Stimulate Aggregation-independent Tyrosine Phosphorylation of CD31 in Platelets. EVIDENCE FOR THE INVOLVEMENT OF Src FAMILY KINASES
J. Biol. Chem.,
August 25, 2000;
275(35):
27339 - 27347.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|